Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L6 pseudogene 7 is a non-coding pseudogene found in the human genome and is classified as a processed pseudogene derived from the ribosomal protein L6 gene. Pseudogenes are genomic sequences similar to functional genes but are typically non-functional due to mutations or lack of regulatory elements; RPL6P7 is not known to be transcribed or translated and does not participate in any biological processes or disease mechanisms. Pseudogenes like RPL6P7 often result from retrotransposition or genomic duplication events and are dispersed throughout the genome, but they do not function as active proteins, enzymes, receptors, or drug targets. RPL6P7 is occasionally mislabeled as a gene target due to its similarity in nomenclature to authentic ribosomal protein genes, but it is not a true druggable target, nor is it involved in cell biology or disease. The actual gene encoding functional ribosomal protein L6 is RPL6 (not RPL6P7). If you require data on the protein-coding ribosomal protein L6, consult sources for "60S ribosomal protein L6" or "RPL6" instead; for RPL6P7, structured information is null for biological function, disease, and targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L6 pseudogene 7 (RPL6P7).